Cargando…
Objective and patient‐based measures of chronic rhinosinusitis in people with cystic fibrosis treated with highly effective modulator therapy
Autores principales: | Beswick, Daniel M., Humphries, Stephen M., Miller, Jessa E., Balkissoon, Connor D., Khatiwada, Aastha, Vladar, Eszter K., Ramakrishnan, Vijay R., Lynch, David A., Taylor‐Cousar, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790219/ https://www.ncbi.nlm.nih.gov/pubmed/35595546 http://dx.doi.org/10.1002/alr.23016 |
Ejemplares similares
-
Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del
por: Beswick, Daniel M., et al.
Publicado: (2022) -
Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status: Deep Learning CT Analysis and Patient-reported Outcomes
por: Beswick, Daniel M., et al.
Publicado: (2022) -
The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
por: Lommatzsch, Sherstin T., et al.
Publicado: (2019) -
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
por: Shteinberg, Michal, et al.
Publicado: (2020) -
Management of pregnancy in cystic fibrosis
por: Montemayor, Kristina, et al.
Publicado: (2022)